Terbutaline is an asthma medication that is commonly used to treat preterm labor. Terbutaline is sold under the brand names Brethine and Bricanyl. Recent studies have shown a link between the use of Terbutaline during pregnancy and an increased risk of brain damage and cognitive deficits in the baby. A recent study conducted at Duke University illustrated the risk of Terbutaline to infants.
The study showed that the use of Terbutaline might leave the brains of children susceptible to other chemicals ubiquitously present in the environment. The study suggests that certain early drug or chemical exposures can predispose people to particular ailments. Recently, the National Asthma Education and Prevention Program has recommended that Terbutaline no longer be given to women with mild intermittent asthma while they are pregnant.
As early as 1997 the FDA issued its first warning about the use of Terbutaline Sulfate for the treatment and prevention of preterm labor. Terbutaline sulfate, in various dosage forms, has been approved by FDA for the treatment of asthma but it has be given to pregnant women subcutaneously, to stop early labor. The use of Terbutaline sulfate to treat preterm labor is an unapproved or “off-label” use. Premature labor occurs in approximately 20 percent of all pregnancies in the United States.
Of those, an estimated 1 million women annually are treated with Terbutaline or related drugs to halt the early contractions. The drugs administered to pregnant women also penetrate to the unborn baby where they affect brain development.
Legal Help For Victims Affected By Terbutaline
If you or a loved one took Terbutaline and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us anytime at 1-800-YOURLAWYER (1-800-968-7529).